Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial

Autor: Bylicki, Olivier, Guisier, Florian, Scherpereel, Arnaud, Daniel, Catherine, Swalduz, Aurélie, Grolleau, Emmanuel, Bernardi, Marie, Hominal, Stephane, Prevost, Jean.Briac, Pamart, Guillaume, Marques, Marie.Héléne, Cloarec, Nicolas, Deshayes, Simon, Raimbourg, Judith, Veillon, Rémi, Oulkhouir, Youssef, Audigier Valette, Clarisse, Subtil, Fabien, Chouaïd, Christos, Greillier, Laurent
Zdroj: In Lung Cancer August 2024 194
Databáze: ScienceDirect
Externí odkaz: